Neuroscience: Biomarkers and Personalized Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 659
Special Issue Editor
Special Issue Information
Dear Colleagues,
Background & history of this topic: Biological markers represent quantitative measures providing information about disease phases and progress as well as response to treatment. Detecting specific biomarkers may augment the understanding of the aetiology and pathogenesis, with particular emphasis on the preclinical and premorbid phases of the disease. Specifically, the study of biomarkers in the brain may refine the way psychiatric and neurological conditions are diagnosed, leading to more effective and personalized treatments.
Aim and scope of the special issue: Giving the promising potential in neuroscience biomarkers and personalized medicine, the aim of this Special Issue is to improve the scientific evidence surrounding neurocognitive and psychiatric disorders to provide significant data for early diagnosis and effective treatment. We encourage authors to submit papers pertaining to neurodegenerative disorders, especially Alzheimer’s disease. An area of special emphasis is the brain–behaviour relationship in aging science, too, with particular focus on cognitive and motor predictors of decline. Manuscripts reporting scientific efforts made to identify biomarkers for prevention, diagnosis, and drug and psychotherapy treatment response in psychiatric patients are also welcome.
Cutting-edge research: The aim here is to explore and treat the mechanisms of the central nervous system to further understand neural and behavioural processes associated with normal and pathological brain aging and psychiatric disorders. We also offer researchers a platform to share new ideas and advancements relating to all aspects of digital health and virtual health care for healthy and cognitively impaired older adults as well as psychiatric patients.
What kind of papers we are soliciting: We encourage the submission of original research articles, narrative and systematic reviews, clinical trials, perspectives, opinions, and study protocols relevant to this Special Issue.
Dr. Davide Maria Cammisuli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aging neuroscience
- biomarkers
- neuropsychological predictors
- motor predictors
- neurodegenerative disorders
- psychiatric disorders
- technological equipment
- treatment
